Kala Bio (KALA) Stock Price, Quote, News & History | Benzinga

Kala Bio Inc (KALA) Stock Price, Quote, News & History

KALANASDAQ

Trade with Public

Trade with Public

$0.9000

0.00130.14%

At close: Aug 19, 5:00 PM EST

$0.8824

-0.0176-1.96%

After Hours: 7:33 PM EST

Earnings: Q2 2026 earnings were released today after the market close

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.93

Close

$0.90

Volume / Avg.

35.59K / 134.01K

Day Range

$0.89 - $0.94

52 Wk Range

0.59 - 1.03K

Market Cap

$16.40M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

1.51%

Days to Cover

2.37

Recent KALA BIO Inc News

Top 3 Health Care Stocks Which Could Blast Off This Quarter

Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)

Avi Kapoor

EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch

Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a potential recurring revenue model.

Vandana Singh

Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-market trading after reporting earnings.

Avi Kapoor

Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-market trading after reporting earnings.

Avi Kapoor

Crude Oil Gains Over 5%; US Inflation Holds Steady At 2.4%

US stocks mixed, Dow down 300 points. Dow down 0.71%, Nasdaq up 0.21%, S&P 500 down 0.13%. Energy sector up 1.4%, consumer staples down 1.6%. US consumer inflation holds steady in Feb, up 2.4% YoY. Equities trading up: CVGI +52%, KALA +36%, ASNS +47%. Equities trading down: KITT -24%, CPB -9%, KOS -19%. Oil up 3.2%, gold down 0.9%, silver down 4.3%, copper down 1.1%. European and Asian markets closed mixed. US markets down for the day. US inflation holds steady. Equities trading mixed. Oil and precious metals prices fluctuating. European and Asian markets also mixed. US markets down for the day. US inflation holds steady. Equities trading mixed. Oil and precious metals prices fluctuating. European and Asian markets also mixed.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-26.06M

Investing Cash Flow (TTM)

-7.02M

Financing Cash Flow (TTM)

-7.38M

Free Cash Flow (TTM)

-26.08M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-40.46M

Analyst Rating and Forecast

4.7

Strong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.82M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.62

Earnings Yield % (TTM)

-11350.84%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.56

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$22.48M

Total Cash

$1.76M

Debt to Equity

-

Issuance of Debt (TTM)

-$22.48M

Repayment of Debt (TTM)

-$22.48M

Key Statistics

Open

$0.93

Close

$0.90

Volume / Avg.

35.59K / 134.01K

Day Range

$0.89 - $0.94

52 Wk Range

0.59 - 1.03K

Market Cap

$16.40M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

1.51%

Days to Cover

2.37

About

Sector

Health Care

Industry

Biotechnology

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a hum...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kala Bio (KALA) stock?

A

You can purchase shares of Kala Bio (NASDAQ:KALA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kala Bio (KALA) competitors?

A

Other companies in Kala Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Kala Bio (KALA) stock?

A

Kala Bio has a consensus price target of $26.00.

Q

What is the current price for Kala Bio (KALA)?

A

The stock price for Kala Bio (NASDAQ: KALA) is $0.8824 last updated August 19, 2026 at 7:33 PM EDT.

Q

Does Kala Bio (KALA) pay a dividend?

A

There are no upcoming dividends for Kala Bio.

Q

When is Kala Bio (NASDAQ:KALA) reporting earnings?

A

Kala Bio does not have any upcoming earnings scheduled.

Q

Is Kala Bio (KALA) going to split?

A

There is no upcoming split for Kala Bio.

Q

What sector and industry does Kala Bio (KALA) operate in?

A

Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.